Herbs (Global Traditional) · Amazonian
Jaborandi (Pilocarpus jaborandi) (Pilocarpus jaborandi)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Jaborandi (Pilocarpus jaborandi) is an Amazonian plant containing pilocarpine, a muscarinic receptor agonist that stimulates saliva production and reduces intraocular pressure. The FDA has approved isolated pilocarpine from jaborandi for treating dry mouth conditions in Sjögren's syndrome and post-radiation therapy.
Jaborandi is derived from Pilocarpus jaborandi, a shrub native to tropical regions of Brazil and South America. The medicinal parts are the dried leaves, typically prepared as decoctions, powders, fluid extracts, or tinctures, containing the key active compound pilocarpine, an imidazole alkaloid.
Clinical evidence for jaborandi itself is extremely limited, with no randomized controlled trials or meta-analyses identified for the crude herb. One historical review (PMID: 397371) documents its introduction in 1875 for fever and psoriasis treatment, but modern clinical validation exists only for isolated pilocarpine rather than jaborandi leaf extracts. The FDA has approved pilocarpine (derived from jaborandi) for glaucoma and dry mouth, but specific trials on the whole plant are absent.
Traditional dosages include: powdered leaves 5-60 grains; fluid extract 10-30 drops; tincture 1/2-1 drachm. For isolated pilocarpine: 1/20-1/4 grain. No modern standardized extract trials exist, and leaves contain variable pilocarpine levels without established standardization. Consult a healthcare provider before starting any new supplement.
Jaborandi (Pilocarpus jaborandi) is a medicinal shrub rather than a dietary food source, so conventional macronutrient profiling is not applicable in traditional nutritional terms. However, the following bioactive compounds and phytochemical constituents are documented: Primary alkaloids dominate the pharmacological profile, with pilocarpine being the most significant at approximately 0.5–1.0% dry weight concentration in leaves (some analyses report up to 0.6–0.9% in cultivated Brazilian specimens). Isopilocarpine is present as a diastereomeric companion alkaloid at roughly 0.1–0.3% dry weight. Pilocarpidine and pilosine (also called jaborine) are additional imidazole alkaloids present at trace to minor concentrations (estimated 0.05–0.2% dry weight). Epiisopiloturine and related minor alkaloids contribute to the overall alkaloid pool, collectively estimated at 0.8–1.5% total alkaloid content in dried leaf material. Flavonoids including rutin, quercetin glycosides, and kaempferol derivatives are present in the leaf matrix, though precise concentrations in wild-harvested Pilocarpus jaborandi are not well-quantified in peer-reviewed literature; estimates from related Pilocarpus species suggest flavonoid content of 0.3–0.8% dry weight. Essential oil constituents include terpene compounds (beta-caryophyllene, limonene, sabinene) at approximately 0.1–0.5% in leaf tissue. Tannins are present at low levels estimated at 1–3% dry weight based on genus-wide analyses. Regarding macronutrients: as a dried leaf material, approximate crude protein content is estimated at 10–15% dry weight (consistent with many tropical shrub leaves), crude fiber at 15–25% dry weight, and lipid content at 2–5% dry weight, though these values are derived from phytochemical class comparisons rather than direct food-grade nutritional assays for this specific species. Minerals documented in Pilocarpus species leaves include potassium, calcium, and magnesium at levels consistent with tropical foliage (potassium ~1–2% dry weight, calcium ~0.5–1.5% dry weight), though species-specific mineral panels for P. jaborandi are limited in published literature. Bioavailability note: Pilocarpine is well-absorbed through mucous membranes and ocular tissue; oral bioavailability of whole-leaf alkaloids varies significantly due to first-pass metabolism. The plant is not consumed as a food ingredient and no dietary reference intake data exists. All quantitative estimates for non-alkaloid fractions carry moderate-to-high uncertainty due to limited direct assay data on this specific species.
Pilocarpine, jaborandi's primary alkaloid, acts as a selective muscarinic receptor agonist, particularly targeting M3 receptors in salivary and lacrimal glands. This activation stimulates cyclic adenosine monophosphate (cAMP) pathways, increasing secretion of saliva and tears. In the eye, pilocarpine causes pupillary constriction and ciliary muscle contraction, improving aqueous humor drainage and reducing intraocular pressure.
Clinical evidence exists primarily for isolated pilocarpine rather than whole jaborandi extract. Randomized controlled trials demonstrate pilocarpine tablets (5-10mg) significantly increase saliva flow in Sjögren's syndrome patients, with 60-70% experiencing improved dry mouth symptoms. Pilocarpine eye drops (0.5-4%) effectively reduce intraocular pressure in glaucoma patients by 15-25% within 2-4 hours. However, no clinical studies have evaluated whole jaborandi plant preparations for these conditions.
Pilocarpine from jaborandi can cause cholinergic side effects including excessive sweating, nausea, rhinitis, and urinary frequency in 29-68% of users. It may interact with beta-blockers, potentially causing conduction disturbances, and should be avoided with anticholinergic medications that counteract its effects. Contraindications include uncontrolled asthma, acute iritis, and narrow-angle glaucoma when used systemically. Pregnancy safety data is limited, warranting caution during pregnancy and breastfeeding.
